Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024.
Please contact us at IR@philogen.com or follow the link register to the event.
Jun 17, 2024
Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024.
Please contact us at IR@philogen.com or follow the link register to the event.